Review Registration - Organization

This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.

Registration ID: 789798
Submitted by lobbyist on: May 28, 2018 08:56:00 AM
Accepted by Registrar on: May 28, 2018 09:48:59 AM

Designated Filer Information

Keon, James J  
4120 Yonge Street Suite 409  
Toronto, ON, M2P 2B8
416-223-2333
Canada  

Organization Information

Canadian Generic Pharmaceutical Association (CGPA)  
The CGPA's mission is to promote an environment which supports and enhances the provision of affordable generic medications to Canadians and patients around the world. The Association researches and develops positions regarding a wide variety of policies, regulations and legislation that affects our member companies. We promote our sector's interests by publishing material as well as directly contacting government officials, the media and other opinion leaders and decision makers.
4120 Yonge Street Suite 409  
Toronto, BC, M2P 2B8
416-223-2333
Canada  

Relevant Affiliates

The client has no relevant affiliates.

Government or Government Agency Funding


The organization does not receive any funding from a government or government agency.

Other Controlling or Directing Interests

The organization has no other controlling or directing interests.

Active Registration Period

May 28, 2018  
November 28, 2018  

Organization's In-House Lobbyists

 



Name: Connell, Jeff
 
May 28, 2018  
Inactivation Date: December 16, 2018

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Introduction, modification or repeal of legislation, a bill or regulation

Developing a regulatory pathway for biosimilars. Addressing use of brand coupon cards. Protecting the interests of Canada's generic pharmaceutical industry during implementation of the Comprehensive Economic and Trade Agreement. Implementation of commitments made by British Columbia pursuant to its involvement with the pan-Canadian Pharmaceutical Alliance. Use of Ontario reference price. Amendment of the Drug Price Regulation in respect of the Maximum Allowable List Price to bring it in line with pCPA tiered pricing model and elimination of exclusive listings. Payment of distribution fees by the government. Promoting greater utilization of generic prescription medicines. Price increase policy. Scope of listings. National Pharmacare initiative.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Dix, Adrian Minister of Health May 28, 2018
Public Agency Health May 28, 2018

Name: Cox, Jody
 
May 28, 2018  
Inactivation Date: December 16, 2018

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

International Trade

Development, establishment, amendment or termination of any program, policy or decision

Protecting the interests of Canada's generic pharmaceutical industry during implementation of the Comprehensive Economic and Trade Agreement. Canadian negotiating position with United States regarding intellectual property protection for pharmaceutical and biosimilar drugs in trade negotiations. Canadian negotiating position with United States regarding intellectual property protection for pharmaceutical and biosimilar drugs in trade negotiations.

Target Contacts

Target Type Name Title or Constituency Date Added
Public Agency Minister of State for Trade May 28, 2018

Name: Keon, James
 
May 28, 2018  
Inactivation Date: December 16, 2018

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Awarding, amendment or termination of a contract, grant or financial benefit

Development, establishment, amendment or termination of any program, policy or decision

Introduction, modification or repeal of legislation, a bill or regulation

Developing a regulatory pathway for biosimilars. Addressing use of brand coupon cards. Protecting the interests of Canada's generic pharmaceutical industry during implementation of the Comprehensive Economic and Trade Agreement. Implementation of commitments made by British Columbia pursuant to its involvement with the pan-Canadian Pharmaceutical Alliance. Use of Ontario reference price. Amendment of the Drug Price Regulation in respect of the Maximum Allowable List Price to bring it in line with pCPA tiered pricing model and elimination of exclusive listings. Payment of distribution fees by the government. Promoting greater utilization of generic prescription medicines. Price increase policy. Scope of listings. National Pharmacare initiative.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Dix, Adrian Minister of Health May 28, 2018
Public Agency Health May 28, 2018